Volume | 902,517 |
|
|||||
News | - | ||||||
Day High | 70.00 | Low High |
|||||
Day Low | 68.14 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Intra Cellular Therapies Inc | ITCI | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
69.78 | 68.14 | 70.00 | 69.20 | 69.72 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
10,944 | 902,517 | $ 69.16 | $ 62,416,684 | - | 45.50 - 76.11 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:06:32 | 8 | $ 69.00 | USD |
Intra Cellular Therapies (ITCI) Options Flow Summary
Intra Cellular Therapies Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
6.69B | 96.81M | - | 464.37M | -139.67M | -1.44 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Intra Cellular Therapies News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ITCI Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 67.78 | 70.07 | 67.13 | 68.56 | 564,955 | 1.42 | 2.10% |
1 Month | 71.56 | 72.305 | 63.30 | 66.95 | 656,191 | -2.36 | -3.30% |
3 Months | 69.62 | 76.11 | 62.78 | 68.80 | 788,657 | -0.42 | -0.60% |
6 Months | 54.16 | 76.11 | 45.50 | 62.14 | 868,084 | 15.04 | 27.77% |
1 Year | 54.01 | 76.11 | 45.50 | 61.20 | 802,499 | 15.19 | 28.12% |
3 Years | 31.90 | 76.11 | 28.40 | 52.63 | 745,713 | 37.30 | 116.93% |
5 Years | 11.90 | 76.11 | 6.75 | 37.45 | 926,072 | 57.30 | 481.51% |
Intra Cellular Therapies Description
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders. |